NGHIÊN CỨU TÌNH HÌNH VÀ ĐÁNH GIÁ KẾT QUẢ ĐIỀU TRỊ BẰNG THANG ĐIỂM CHẤT LƯỢNG CUỘC SỐNG Ở NGƯỜI BỆNH HỘI CHỨNG RUỘT KÍCH THÍCH ĐẾN PHÒNG KHÁM TIÊU HÓA BỆNH VIỆN ĐA KHOA CÀ MAU NĂM 2022 – 2023

Abstract

Background: Irritable bowel syndrome is a benign disease, but the gastrointestinal symptoms persist for a long time, there is no specific treatment, and significantly affecting the patient's quality of life. Objectives: To determine the prevalence and types of diseases in patients with irritable bowel syndrome. To evaluate of the quality of life of patients with irritable bowel syndrome before and after treatment by IBS-QoL quality of life scale. Materials and methods: A cross-sectional and prospective descriptive study was conducted on 110 patients who came for examination at The Gastroenterology Department of Ca Mau General Hospital from 2022 to 2023. Results: The prevalence of patients with irritable bowel syndrome visiting the gastroenterology clinic in Ca Mau General Hospital was 68.2% with the rate of IBS-D, IBS-C, IBS-M, and IBS-U were 29.3%; 28% and 13.4%, respectively. After treatment, the IBS-QoL score of moderate-good quality of life increased from 6.7% to 98.7%. Conclusions: Patients with irritable bowel syndrome came to the gastroenterology clinic of Ca Mau General Hospital for a relatively high prevalence with the types of IBS-D, IBS-C, and IBS-M had similar rates. After treatment, the patient's quality of life improved significantly.